Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1589-1592, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monneret, G.
Right arrow Articles by Lepape, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monneret, G.
Right arrow Articles by Lepape, A.
Related Collections
Right arrow Clinical Immunology
(Clinical Chemistry. 2002;48:1589-1592.)
© 2002 American Association for Clinical Chemistry, Inc.

Technical Briefs

Analytical Requirements for Measuring Monocytic Human Lymphocyte Antigen DR by Flow Cytometry: Application to the Monitoring of Patients with Septic Shock

Guillaume Monneret1a, Nadia Elmenkouri1, Julien Bohe1, Anne-Lise Debard1, Marie-Claude Gutowski1, Jacques Bienvenu1 and Alain Lepape1

1 Immunology Laboratory and Intensive Care Units, Lyon-Sud University Hospital, 69495 Pierre-Bénite, France

aaddress correspondence to this author at: Flow Cytometry Unit, Immunology Laboratory, Lyon-Sud University Hospital, 69495 Pierre-Bénite, France; fax 33-4-7886-3344, e-mail guillaume.monneret@chu-lyon.fr

The first 300 words of the full text of this article appear below.

The concept of immunoparalysis has recently been proposed for explaining the failure of 20 years of clinical trials using antiinflammatory drugs in sepsis (1)(2)(3). Immunoparalysis is characterized mainly by the paralysis of monocytic functions. In particular, because of decreased expression of HLA-DR, antigen-presenting capacity is severely depressed (4)(5). Recent clinical studies have confirmed that among a large panel of activation markers expressed on different leukocyte populations (i.e., neutrophils, lymphocytes, and monocytes), decreased HLA-DR expression on monocytes constitutes a reliable marker of immunoparalysis and seems to correlate with an increased risk for fatal outcome (6)(7)(8). Nevertheless, little work has been devoted to analytical aspects related to its measurement by flow cytometry. Indeed, flow cytometry cannot yet be considered a standardized tool, and many variables must be taken into account for ensuring the technical quality of results (9). This is especially required in clinical research when clinicians and immunologists are assessing the potential value of a new marker, as is presently the case for monitoring septic patients, and it is particularly true for the determination of HLA-DR, which is considered a rapidly up- or down-regulated marker (5)(10). The present study was designed to determine whether different protocol procedures could lead to discrepant results for HLA-DR measurements. After establishing a reliable protocol, the second objective was to demonstrate immunoparalysis in monitoring patients with septic shock.

Samples of peripheral blood were collected in EDTA anticoagulant tubes. Staining was performed on whole blood using PC5-labeled CD45, fluorescein isothiocyanate (FITC)-labeled CD14 (Immunotech), and phycoerythrin-labeled HLA-DR (clone L243; Becton Dickinson). Samples were lysed manually by use of FACS lysing solution (Becton Dickinson) or the automated Q-Prep system (Beckman-Coulter). Cells were analyzed on a Coulter EPICS . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Immunol.Home page
A. Pachot, M.-A. Cazalis, F. Venet, F. Turrel, C. Faudot, N. Voirin, J. Diasparra, N. Bourgoin, F. Poitevin, B. Mougin, et al.
Decreased Expression of the Fractalkine Receptor CX3CR1 on Circulating Monocytes as New Feature of Sepsis-Induced Immunosuppression
J. Immunol., May 1, 2008; 180(9): 6421 - 6429.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W.-D. Docke, C. Hoflich, K. A. Davis, K. Rottgers, C. Meisel, P. Kiefer, S. U. Weber, M. Hedwig-Geissing, E. Kreuzfelder, P. Tschentscher, et al.
Monitoring Temporary Immunodepression by Flow Cytometric Measurement of Monocytic HLA-DR Expression: A Multicenter Standardized Study
Clin. Chem., December 1, 2005; 51(12): 2341 - 2347.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. Le Tulzo, C. Pangault, L. Amiot, V. Guilloux, O. Tribut, C. Arvieux, C. Camus, R. Fauchet, R. Thomas, and B. Drenou
Monocyte Human Leukocyte Antigen-DR Transcriptional Downregulation by Cortisol during Septic Shock
Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1144 - 1151.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.